Published in Curr Opin Rheumatol on January 01, 2014
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis. N Engl J Med (2017) 4.55
Eosinophils in vasculitis: characteristics and roles in pathogenesis. Nat Rev Rheumatol (2014) 1.24
Eosinophilic granulomatosis with polyangiitis: an overview. Front Immunol (2014) 0.95
Serum biomarkers in patients with relapsing eosinophilic granulomatosis with polyangiitis (Churg-Strauss). PLoS One (2015) 0.89
Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab. Am J Hematol (2014) 0.82
Antiproteinase 3 Positive Eosinophilic Granulomatosis with Polyangiitis Presenting with Heart Failure and Intraventricular Thrombosis. Case Rep Rheumatol (2017) 0.75
Eosinophilic granulomatosis with polyangiitis (formerly known as Churg-Strauss syndrome) as a differential diagnosis of hypereosinophilic syndromes. Respir Med Case Rep (2017) 0.75
Updates in ANCA-associated vasculitis. Eur J Rheumatol (2016) 0.75
Systemic granulomatous diseases associated with multiple palpable masses that may involve the breast: case presentation and an approach to the differential diagnosis. Case Rep Med (2014) 0.75
A case report and literature review of Churg-Strauss syndrome presenting with myocarditis. Medicine (Baltimore) (2016) 0.75
Eosinophils in Autoimmune Diseases. Front Immunol (2017) 0.75
Eosinophilic Granulomatosis with Polyangiitis Presented as Acute Polyneuropathy and Cerebral Vasculitis. Exp Neurobiol (2017) 0.75
Two cases of atypical hemolytic uremic syndrome (aHUS) and eosinophilic granulomatosis with polyangiitis (EGPA): a possible relationship. CEN Case Rep (2017) 0.75
Dickkopf-1 is a master regulator of joint remodeling. Nat Med (2007) 7.29
Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med (2012) 6.93
Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem (2003) 6.63
Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA (2012) 4.58
Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis. Arthritis Rheum (2007) 3.02
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A(4). Nat Med (2002) 2.94
Regulatory T cells protect from local and systemic bone destruction in arthritis. J Immunol (2010) 2.70
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun (2012) 2.65
Reconstructing the development of Baltic sea eutrophication 1850-2006. Ambio (2012) 2.56
Impact of climate change on ecological quality indicators and biogeochemical fluxes in the Baltic sea: a multi-model ensemble study. Ambio (2012) 2.23
Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) (2009) 2.14
Treg cells suppress osteoclast formation: a new link between the immune system and bone. Arthritis Rheum (2007) 2.12
High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med (2006) 2.09
Relations of vitamin D status, gender and type 2 diabetes in middle-aged Caucasians. Acta Diabetol (2014) 2.07
Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med (2011) 2.05
Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death. Hum Pathol (2004) 1.84
Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Eur J Cancer (2007) 1.83
Early structural changes in cartilage and bone are required for the attachment and invasion of inflamed synovial tissue during destructive inflammatory arthritis. Ann Rheum Dis (2012) 1.81
Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study. Rheumatology (Oxford) (2011) 1.74
How antirheumatic drugs protect joints from damage in rheumatoid arthritis. Arthritis Rheum (2008) 1.74
Heme oxygenase attenuates allergen-induced airway inflammation and hyperreactivity in guinea pigs. Am J Physiol Lung Cell Mol Physiol (2004) 1.72
Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage? Ann Rheum Dis (2010) 1.71
Outcome and prognostic factors during the course of primary small-vessel vasculitides. J Rheumatol (2006) 1.69
Risk of infections in rheumatoid arthritis patients treated with tocilizumab. Rheumatology (Oxford) (2011) 1.68
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis (2010) 1.67
Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum (2009) 1.65
Electrocardiographic and further predictors for permanent pacemaker requirement after transcatheter aortic valve implantation. Europace (2010) 1.59
Blockade of the hedgehog pathway inhibits osteophyte formation in arthritis. Ann Rheum Dis (2012) 1.58
Pachydermodactyly: a review. Curr Rheumatol Rep (2014) 1.56
Notch signalling regulates fibroblast activation and collagen release in systemic sclerosis. Ann Rheum Dis (2011) 1.56
Mechanisms of Disease: the link between RANKL and arthritic bone disease. Nat Clin Pract Rheumatol (2005) 1.55
The role of Wnt proteins in arthritis. Nat Clin Pract Rheumatol (2008) 1.52
Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritis. Arthritis Res Ther (2011) 1.51
Neuropsychological decline after catheter ablation of atrial fibrillation. Heart Rhythm (2010) 1.50
Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med (2014) 1.50
Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J (2005) 1.49
Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology (2014) 1.47
Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis. Am J Pathol (2002) 1.44
Which standard biomarkers are useful for the evaluation of myocardial injury after pulmonary vein isolation with cryoballoon? Kardiol Pol (2011) 1.41
Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo. Arthritis Rheum (2009) 1.40
Atrial fibrillation ablation: Limitations of pulmonary vein ablation catheter technology. Cardiol J (2014) 1.39
Major determinants of myocardial injury after pulmonary vein isolation with radiofrequency ablation. Kardiol Pol (2012) 1.39
Are the Polyomaviruses BK and JC Associated with Opportunistic Infections, Graft-versus-Host Disease, or Worse Outcomes in Adult Patients Receiving Their First Allogeneic Stem Cell Transplantation with Low-Dose Alemtuzumab? Acta Haematol (2017) 1.38
Three-dimensional imaging of single isolated cell nuclei using optical projection tomography. Opt Express (2005) 1.38
Treatment with imatinib prevents fibrosis in different preclinical models of systemic sclerosis and induces regression of established fibrosis. Arthritis Rheum (2009) 1.36
Dual inhibition of c-abl and PDGF receptor signaling by dasatinib and nilotinib for the treatment of dermal fibrosis. FASEB J (2008) 1.33
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome. Kidney Int (2013) 1.33
Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum (2003) 1.31
Positron emission tomography (PET): evaluation of chronic periaortitis. Arthritis Rheum (2005) 1.29
12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J Immunol (2009) 1.27
Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis. Am J Pathol (2004) 1.24
Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum (2007) 1.23
Targeting interleukin-5 in refractory and relapsing Churg-Strauss syndrome. Ann Intern Med (2011) 1.22
High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis (2011) 1.21
Rho-associated kinases are crucial for myofibroblast differentiation and production of extracellular matrix in scleroderma fibroblasts. Arthritis Rheum (2008) 1.20
IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis (2011) 1.18
Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care (2012) 1.17
Management of hepatitis C virus-related mixed cryoglobulinemia. Am J Med (2010) 1.17
IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis (2014) 1.17
Src kinases in systemic sclerosis: central roles in fibroblast activation and in skin fibrosis. Arthritis Rheum (2008) 1.16
HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism. FASEB J (2006) 1.16
Prospective randomized comparison of durability of bidirectional conduction block in the cavotricuspid isthmus in patients after ablation of common atrial flutter using cryothermy and radiofrequency energy: the CRYOTIP study. Heart Rhythm (2009) 1.14
Sirolimus treatment for pulmonary lymphangioleiomyomatosis. Ann Intern Med (2007) 1.14
Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis. Arthritis Rheum (2010) 1.14
Atypical haemolytic uraemic syndrome with underlying glomerulopathies. A case series and a review of the literature. Nephrol Dial Transplant (2013) 1.11
Pulmonary vein diameter reduction after radiofrequency catheter ablation for paroxysmal atrial fibrillation evaluated by contrast-enhanced three-dimensional magnetic resonance imaging. Circulation (2003) 1.11
CD44 is a determinant of inflammatory bone loss. J Exp Med (2005) 1.10
Arthritis induces lymphocytic bone marrow inflammation and endosteal bone formation. J Bone Miner Res (2004) 1.09
TLR-mediated induction of negative regulatory ligands on dendritic cells. J Mol Med (Berl) (2008) 1.09
The SEM6A6 locus is not associated with granulomatosis with polyangiitis or other forms of antineutrophil cytoplasmic antibody-associated vasculitides in Europeans: comment on the article by Xie et al. Arthritis Rheumatol (2014) 1.09
WNT5A is induced by inflammatory mediators in bone marrow stromal cells and regulates cytokine and chemokine production. J Bone Miner Res (2012) 1.08
Chronic periaortitis: a fibro-inflammatory disorder. Best Pract Res Clin Rheumatol (2009) 1.07
Inhibition of glycogen synthase kinase 3β induces dermal fibrosis by activation of the canonical Wnt pathway. Ann Rheum Dis (2011) 1.07
Outcomes of atrial fibrillation ablation in patients with metabolic syndrome. J Am Coll Cardiol (2013) 1.06
The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss. J Immunol (2009) 1.06
Vascular cell adhesion molecule 1 as a predictor of severe osteoarthritis of the hip and knee joints. Arthritis Rheum (2009) 1.05
A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis. Rheumatology (Oxford) (2010) 1.02
Churg-Strauss syndrome: update on pathophysiology and treatment. Curr Opin Rheumatol (2012) 1.02
Tumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivo. Arthritis Res Ther (2005) 1.01
Combined effects of global climate change and regional ecosystem drivers on an exploited marine food web. Glob Chang Biol (2013) 1.01
Fibrosis--A Common Pathway to Organ Injury and Failure. N Engl J Med (2015) 1.01
Retroperitoneal fibrosis. Best Pract Res Clin Rheumatol (2012) 1.00
Uraemic pruritus: clinical characteristics, pathophysiology and treatment. Drugs (2009) 1.00
Lysophosphatidylcholine-induced modulation of Ca(2+)-activated K(+)channels contributes to ROS-dependent proliferation of cultured human endothelial cells. J Mol Cell Cardiol (2004) 0.99
Anti-interleukin-5 therapy in severe asthma. Eur Respir Rev (2013) 0.99
In vivo RNAi-mediated silencing of TAK1 decreases inflammatory Th1 and Th17 cells through targeting of myeloid cells. Blood (2010) 0.98
Biologic treatment of large-vessel vasculitides. Curr Opin Rheumatol (2012) 0.97
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum (2006) 0.97
Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients. Rheumatology (Oxford) (2012) 0.97
Gabapentin in the treatment of uremic itch: an index case and a pilot evaluation. J Nephrol (2005) 0.97
Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis. Arthritis Rheum (2012) 0.96
Ear, nose and throat manifestations of Churg-Strauss syndrome. Acta Otolaryngol (2006) 0.96
Combining functional magnetic resonance imaging with mouse genomics: new options in pain research. Neuroreport (2010) 0.96